HBM Partners raises €90 million second fund
This article was originally published in Scrip
Executive Summary
The investment management group, HBM Partners, has secured a first closing of €90 million for its HBM BioCapital II fund, which will now invest in privately owned European and North American companies in the pharma, medical device and diagnostics sectors, it said. The fund's focus will be on revenue-generating and late-stage product development companies, supporting them in growing and internationalising their businesses. Investments are expected to range between €5 million and €15 million.